Vilnis Liepins - AS Olainfarm Insider

AS Olainfarm -- Germany Stock  

EUR 8.8  0.09  1.01%

Director of Research and Development Department

Mr. Vilnis Liepins serves as Director of Research and DevelopmentDepartment of Joint stock company Olainfarm. He has more than a 15year long experience in the field of chemistry and pharmaceutics. He joined JSC Olainfarm in 2013, when he transferred from Syntagon Baltic Ltd., where he was the Group Leader. He obtained his doctoral degree at Stockholms universitet and did his internship at the MaxPlanck Institute in Germany. He obtained a masters degree in organic chemistry and a bachelors degree in chemical technology at Rigas Tehniska universitate .
        

Management Efficiency

The company has return on total asset (ROA) of 6.33 % which means that it generated profit of $6.33 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 12.08 % meaning that it generated $12.08 on every $100 dollars invested by stockholders.
The company has accumulated 28.23 M in total debt with debt to equity ratio (D/E) of 30.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AS Olainfarm has Current Ratio of 1.92 which is within standard range for the sector.

Similar Executives

Showing few of many executives

DIRECTOR Since

Peter VoserInternational Business Machines
2015
Roxanne AustinAbbVie Inc
2013
Robert AlpernAbbVie Inc
2013
Frederick WaddellInternational Business Machines
2017
David FarrInternational Business Machines
2012
Andrew LiverisInternational Business Machines
2010
Hutham OlayanInternational Business Machines
2016
Edward RappAbbVie Inc
2013
Michael EskewInternational Business Machines
2005
Walter McNerneyInternational Business Machines
2009
Frederick WaddellAbbVie Inc
2013
Glenn TiltonAbbVie Inc
2013
William BurnsideAbbVie Inc
2013
Kenneth ChenaultInternational Business Machines
2016
James OwensInternational Business Machines
2006
Sidney TaurelInternational Business Machines
2001
Mark FieldsInternational Business Machines
2016
Edward LiddyAbbVie Inc
2013
Brett HartAbbVie Inc
2016
Joan SperoInternational Business Machines
2004
W McNerneyInternational Business Machines
2009

Entity Summary

AS Olainfarm (UU4) is traded on Frankfurt Stock Exchange in Germany. and employs 25 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add AS Olainfarm to your portfolio

Top Management

AS Olainfarm Leadership Team
Valentina Andrejeva, Chairman
Vladimirs Krusinskis, Director
Vilnis Liepins, Director
Veranika Dubitskaya, Executive
Marjana IvanovaJevsejeva, CEO
Vitalijs Kiselovs, Director
Salvis Lapins, Executive
Aleksandrs Raicis, Executive, Ph.D
Jelena Cudinovskiha, Director
Mihails Raizbergs, Director
Olegs Grigorjevs, Director
Gunta Veismane, Executive
Ivars Godmanis, Chairman, Ph.D
Valerijs Maligins, Chairman
Martins Tambaks, CFO, MBA
Jevgenijs Goncars, Director
Inga Liscika, Director, CPA
Valentina Andreeva, Executive
Andris Krumins, Executive
Gita Silina, Director
Jelena Borcova, Executive
Volodimir Krivozubovs, Executive
Geliia Gildeeva, Executive
Genadijs Melnis, Director
Ingrida Circene, Executive

Stock Performance

AS Olainfarm Performance Indicators